Intestinal permeability and immune‐inflammatory markers in patients with idiosyncratic drug‐induced liver injury, drug‐induced steatosis and metabolic dysfunction–associated steatotic liver disease (MASLD).
Saved in:
| Title: | Intestinal permeability and immune‐inflammatory markers in patients with idiosyncratic drug‐induced liver injury, drug‐induced steatosis and metabolic dysfunction–associated steatotic liver disease (MASLD). |
|---|---|
| Authors: | Di Zeo‐Sánchez, Daniel E.1,2 (AUTHOR), Díaz‐Alberola, Irene1 (AUTHOR), Pinazo‐Bandera, José María1 (AUTHOR), García‐Cortés, Miren1,2 (AUTHOR), Sanabria‐Cabrera, Judith1 (AUTHOR), Robles‐Díaz, Mercedes1,2 (AUTHOR), Álvarez‐Álvarez, Ismael1,2 (AUTHOR), Lucena, M. Isabel1,2 (AUTHOR) lucena@uma.es, Andrade, Raúl J.1,2 (AUTHOR) andrade@uma.es, Villanueva‐Paz, Marina1,2 (AUTHOR), Stephens, Camilla1,2 (AUTHOR) |
| Source: | British Journal of Pharmacology. Nov2025, Vol. 182 Issue 21, p5303-5316. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
